Invited Speaker | Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials
Dr. Rowe has well over a decade of research experience spanning from pre-clinical to late phase innovative medical therapy development programs, primarily in respiratory (and cardiovascular) medicine within the pharma industry. He has been directly responsible for medical strategy and lifecycle management of several Chronic Obstructive Pulmonary Disease (COPD), asthma, thrombosis, and cardiovascular medicines. Dr. Rowe is an active member of several national and international societies and he recently served as Vice Chair of the Drug, Device, Discovery, and Development Committee of the American Thoracic Society (ATS) and has received the distinction of being named a Fellow of the society. He has a primary interest in promoting international medical research collaboration and innovation across government, academia, and industry. In his current role, Dr. Rowe is responsible for building and leading a Global Medical team and strategy within the Immunology space for novel compounds in mid and late stage development, in various therapeutic disease state indications.
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.